The oral bioavailability of ARD-2128 in mice reached 67% as it effectively reduced the expression of AR in tumor tissues and inhibited the expression of AR regulatory genes, thereby effectively inhibiting the growth of the tumors in the mice, without any signs of toxicity. Here, AR is linked to neoplasm.